Skip to main content
Clinical Trials/CTRI/2021/04/032623
CTRI/2021/04/032623Not yet recruitingPhase 3

EFFICACY OF VIRECHANA KARMA AND UDWARTANA KARMA IN THE MANAGEMENT OF STHAULYA (OBESITY) AN OPEN LABELED RANDOMIZED COMPARATIVE CLINICAL TRIAL

Government Akhandanand Ayurved Mahavidyalaya1 site in 1 country30 target enrollmentStarted: April 15, 2021Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To reduce weight gain (obesity) in the patients

Study Overview

Brief Summary

Obesityis an alternate cause of death worldwide, with increasing prevalence in adultsand children. It is one of themost serious public health problems of the 21st century. Thoughmodern system of medicine has its own therapeutic modalities in tacklingobesity, they are very commonly associated with many adverse effects. Surgerydone for fat removal has so many temporary and long term complications likeBleeding, Internal hernia, Hair loss etc. Considering this, the globalpopulation is enthusiastically looking towards effective natural remedies. Obesity is a serious problem and an effective solutionis needed to find out.  Ayurveda hassolution to this current problem Ayurveda not only treat Obesity butalso treats a person who is obese or overweight.

Thus,Obesity is a serious problem and a serious solution is needed to find out. Sothis disease is selected for research work.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients between the age group of 18 to 60 years with classical signs and symptoms of Sthaulya.
  • Patients having BMI (Body Mass Index) greater and equal to 25 and less than equal to 35 will be taken for the study.
  • In Shodhana group Virechana Yogya as per Ayurvedic Classic will be included.

Exclusion Criteria

  • Patients having age less than 18 and greater than 60 will be excluded.
  • Known case of serious Cardiac, Renal or Hepatic diseases, Hypertension, AIDS, STD, TB etc.
  • Obesity due to drugs e.g. Anticonvulsant, Antipsychotics, Beta-blockers etc.
  • Pregnant and lactating women.
  • BMI: less than 25 and greater than 35 will be excluded.
  • In Shodhana group Virechana Ayogya as per Ayurvedic Classics will be excluded.

Outcomes

Primary Outcomes

To reduce weight gain (obesity) in the patients

Time Frame: 21 days

Secondary Outcomes

  • To improve quality of life of obesity patients(35 days)

Investigators

Sponsor
Government Akhandanand Ayurved Mahavidyalaya
Sponsor Class
Other [Government Ayurvedic college and Hospital]

Study Sites (1)

Loading locations...

Similar Trials